Prudential Financial Inc. Reduces Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Prudential Financial Inc. cut its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 12.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 161,493 shares of the company's stock after selling 22,551 shares during the period. Prudential Financial Inc. owned 0.33% of Prestige Consumer Healthcare worth $12,611,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the business. Intech Investment Management LLC bought a new stake in Prestige Consumer Healthcare in the third quarter valued at $620,000. Citigroup Inc. lifted its position in shares of Prestige Consumer Healthcare by 66.6% in the 3rd quarter. Citigroup Inc. now owns 76,772 shares of the company's stock worth $5,535,000 after purchasing an additional 30,677 shares during the period. Cerity Partners LLC boosted its stake in shares of Prestige Consumer Healthcare by 103.9% during the 3rd quarter. Cerity Partners LLC now owns 6,347 shares of the company's stock valued at $458,000 after purchasing an additional 3,234 shares in the last quarter. BNP Paribas Financial Markets increased its position in shares of Prestige Consumer Healthcare by 276.2% during the third quarter. BNP Paribas Financial Markets now owns 17,379 shares of the company's stock valued at $1,253,000 after buying an additional 12,759 shares during the period. Finally, Townsquare Capital LLC raised its stake in Prestige Consumer Healthcare by 8.8% in the third quarter. Townsquare Capital LLC now owns 77,168 shares of the company's stock worth $5,564,000 after buying an additional 6,249 shares in the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on PBH. Oppenheimer upped their target price on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a report on Thursday, February 13th. Royal Bank of Canada upped their price target on Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a "sector perform" rating in a research note on Friday, March 21st. StockNews.com raised Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Tuesday, March 18th. Raymond James raised shares of Prestige Consumer Healthcare to a "moderate buy" rating in a research report on Thursday, December 19th. Finally, Sidoti lowered shares of Prestige Consumer Healthcare from a "buy" rating to a "neutral" rating and set a $90.00 price target for the company. in a research note on Monday, December 9th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, Prestige Consumer Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $93.33.

Prestige Consumer Healthcare Stock Down 0.1 %

Shares of NYSE PBH traded down $0.05 during trading on Tuesday, reaching $85.93. The company had a trading volume of 730,056 shares, compared to its average volume of 274,486. The business's 50-day moving average is $83.58 and its 200 day moving average is $79.25. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The stock has a market cap of $4.26 billion, a PE ratio of 20.12, a P/E/G ratio of 2.69 and a beta of 0.46. Prestige Consumer Healthcare Inc. has a 12-month low of $62.35 and a 12-month high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. As a group, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Insider Activity at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the stock in a transaction on Monday, March 10th. The stock was sold at an average price of $90.00, for a total transaction of $151,020.00. Following the sale, the senior vice president now directly owns 17,157 shares in the company, valued at approximately $1,544,130. This trade represents a 8.91 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.60% of the stock is owned by insiders.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.